PMID- 30382579 OWN - NLM STAT- MEDLINE DCOM- 20200408 LR - 20240102 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 234 IP - 5 DP - 2019 May TI - Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis. PG - 6746-6757 LID - 10.1002/jcp.27421 [doi] AB - Recent evidence has highlighted that long noncoding RNAs (lncRNA) are associated with many diseases, particularly cancer. However, current understanding of the lncRNA deleted in lymphocytic leukemia 1 (DLEU1) in pancreatic ductal adenocarcinoma (PDAC) remains limited. Our studies indicated that the DLEU1 expression level was upregulated in PDAC tissue samples compared with adjacent normal tissue. Moreover, the aberrant overexpression of DLEU1 indicated poor prognosis of patients with PDAC. Loss-of-function experiments revealed that DLEU1 knockdown inhibited the proliferation, migration, and invasion of PDAC cells in vitro and decreased tumor growth in vivo. Bioinformatics analysis predicted that miR-381 potentially targeted the DLEU1 3'-untranslated region (UTR), suggesting an interaction between miR-381 and DLEU1. Furthermore, miR-381 also targeted the chemokine receptor-4 (CXCR4) messenger RNA 3'-UTR, which was validated by luciferase reporter assay. Taken together, our study demonstrated the oncogenic role of DLEU1 in clinical PDAC specimens and cellular experiments, showing the potential involvement of DLEU1/miR-381/CXCR4 pathway. These results provide novel insight into PDAC tumorigenesis. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Gao, Song AU - Gao S AD - Department of Oncology, Shanghai Tenths People's Hospital, Tongji University, Shanghai, China. AD - Tongji University Cancer Center, Shanghai, China. FAU - Cai, Yunyun AU - Cai Y AD - Department of Integrated Traditional Western Medicine, Minhang Branch of Fudan University of Shanghai Cancer Center, Shanghai, China. FAU - Zhang, Hu AU - Zhang H AD - Shanghai Geriatric Institute of Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. FAU - Hu, Fei AU - Hu F AD - Department of Oncology, Shanghai Tenths People's Hospital, Tongji University, Shanghai, China. AD - Tongji University Cancer Center, Shanghai, China. FAU - Hou, Lengchen AU - Hou L AD - Department of Anesthesiology, Shanghai 10th People's Hospital, Tongji University, Shanghai, China. FAU - Xu, Qing AU - Xu Q AUID- ORCID: 0000-0002-7107-5451 AD - Department of Oncology, Shanghai Tenths People's Hospital, Tongji University, Shanghai, China. AD - Tongji University Cancer Center, Shanghai, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181101 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (CXCR4 protein, human) RN - 0 (DLEU1 lncRNA, human) RN - 0 (MIRN381 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Long Noncoding) RN - 0 (Receptors, CXCR4) RN - 0 (Tumor Suppressor Proteins) SB - IM MH - Adult MH - Aged MH - Carcinogenesis/genetics MH - Carcinoma, Pancreatic Ductal/*genetics/pathology MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - Female MH - Gene Expression Regulation, Neoplastic/genetics MH - Humans MH - Male MH - MicroRNAs/*genetics MH - Middle Aged MH - Pancreatic Neoplasms/*genetics MH - RNA, Long Noncoding/*genetics MH - Receptors, CXCR4/*genetics MH - Tumor Suppressor Proteins/*genetics OTO - NOTNLM OT - CXCR4 OT - long noncoding RNAs (lncRNA) DLEU1 OT - miR-381 OT - pancreatic ductal adenocarcinoma (PADC) EDAT- 2018/11/02 06:00 MHDA- 2020/04/09 06:00 CRDT- 2018/11/02 06:00 PHST- 2018/05/17 00:00 [received] PHST- 2018/08/21 00:00 [accepted] PHST- 2018/11/02 06:00 [pubmed] PHST- 2020/04/09 06:00 [medline] PHST- 2018/11/02 06:00 [entrez] AID - 10.1002/jcp.27421 [doi] PST - ppublish SO - J Cell Physiol. 2019 May;234(5):6746-6757. doi: 10.1002/jcp.27421. Epub 2018 Nov 1.